Autoimmune hepatitis in 828 Brazilian children and adolescents: clinical and laboratory findings, histological profile, treatments, and outcomes

J Pediatr (Rio J). 2019 Jul-Aug;95(4):419-427. doi: 10.1016/j.jped.2018.04.007. Epub 2018 May 30.

Abstract

Objective: This large study with a long-term follow-up aimed to evaluate the clinical presentation, laboratory findings, histological profile, treatments, and outcomes of children and adolescents with autoimmune hepatitis.

Methods: The medical records of 828 children and adolescents with autoimmune hepatitis were reviewed. A questionnaire was used to collect anonymous data on clinical presentation, biochemical and histological findings, and treatments.

Results: Of all patients, 89.6% had autoimmune hepatitis-1 and 10.4% had autoimmune hepatitis-2. The female sex was predominant in both groups. The median age at symptom onset was 111.5 (6; 210) and 53.5 (8; 165) months in the patients with autoimmune hepatitis 1 and autoimmune hepatitis-2, respectively. Acute clinical onset was observed in 56.1% and 58.8% and insidious symptoms in 43.9% and 41.2% of the patients with autoimmune hepatitis-1 and autoimmune hepatitis-2, respectively. The risk of hepatic failure was 1.6-fold higher for autoimmune hepatitis-2. Fulminant hepatic failure occurred in 3.6% and 10.6% of the patients with autoimmune hepatitis-1 and autoimmune hepatitis-2, respectively; the risk was 3.1-fold higher for autoimmune hepatitis-2. The gamma globulin and immunoglobulin G levels were significantly higher in autoimmune hepatitis-1, while the immunoglobulin A and C3 levels were lower in autoimmune hepatitis-2. Cirrhosis was observed in 22.4% of the patients; biochemical remission was achieved in 76.2%. The actuarial survival rate was 93.0%. A total of 4.6% underwent liver transplantation, and 6.9% died (autoimmune hepatitis-1: 7.5%; autoimmune hepatitis-2: 2.4%).

Conclusions: In this large clinical series of Brazilian children and adolescents, autoimmune hepatitis-1 was more frequent, and patients with autoimmune hepatitis-2 exhibited higher disease remission rates with earlier response to treatment. Patients with autoimmune hepatitis-1 had a higher risk of death.

Keywords: Autoimmune hepatitis; Brasil; Brazil; Clinical; Clínico; Hepatite autoimune; Laboratorial; Laboratory; Outcomes; Resultados; Tratamentos; Treatments.

MeSH terms

  • Adolescent
  • Antibodies, Antinuclear / blood
  • Autoantibodies / analysis
  • Azathioprine / therapeutic use*
  • Biopsy, Needle
  • Brazil
  • Child
  • Female
  • Hepatitis, Autoimmune / drug therapy
  • Hepatitis, Autoimmune / immunology
  • Hepatitis, Autoimmune / pathology*
  • Humans
  • Immunoglobulins / analysis
  • Immunosuppression Therapy
  • Immunosuppressive Agents / therapeutic use*
  • Liver / pathology
  • Magnetic Resonance Imaging
  • Male
  • Prednisone / therapeutic use*
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antibodies, Antinuclear
  • Autoantibodies
  • Immunoglobulins
  • Immunosuppressive Agents
  • Azathioprine
  • Prednisone